3 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Milk Hypersensitivity: new trials by email Literature Review of Milk Hypersensitivity trials Research Report on Milk Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Extension Study of ADP101 ADP101 - Food Allergy | Phase 1 / Phase 2 | Terminated | Alladapt Immunotherapeutics, Inc. | 45 | 2022-03-14 | 2024-03-26 |
| Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy Dupilumab, Placebo - Allergies Food Milk | Phase 2 | Terminated | Andrew J Long, PharmD | 33 | 2021-10-18 | 2026-01-07 |
| Impact of Infant Formula on Resolution of Cow's Milk Allergy Lactobacillus GG, Extensively Hydrolyzed Casein Formula, Amino Acid Formula - Milk Allergy | Phase 2 | Terminated | Massachusetts General Hospital | 49 | 2016-02-01 | 2018-07-13 |
Food Hypersensitivity (2) · Hypersensitivity (2) · Egg Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Nut Hypersensitivity (1) · Peanut Hypersensitivity (1) · Shellfish Hypersensitivity (1) · Wheat Hypersensitivity (1)
Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Food Hypersensitivity (1) · Hypersensitivity (1) · Nut and Peanut Hypersensitivity (1)
dupilumab (1)
Alladapt Immunotherapeutics, Inc. (1) · Andrew J Long, PharmD (1) · Massachusetts General Hospital (1)
United States (3)
Andrew Long, PharmD (1) · Mei-Lun Wang, MD (1) · Wayne G Shreffler, MD, PhD (1)